Computationally repurposing drugs for breast cancer subtypes using a network-based approach

‘De novo’ drug discovery is costly, slow, and with high risk. Repurposing known drugs for treatment of other diseases offers a fast, low-cost/risk and highly-efficient method toward development of efficacious treatments. The emergence of large-scale heterogeneous biomolecular networks, molecular, ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Firoozbakht, Forough, Rezaeian, Iman, Rueda, Luis, Ngom, Alioune
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020161/
https://www.ncbi.nlm.nih.gov/pubmed/35443626
http://dx.doi.org/10.1186/s12859-022-04662-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020161/
https://www.ncbi.nlm.nih.gov/pubmed/35443626
http://dx.doi.org/10.1186/s12859-022-04662-6

Ejemplares similares